[EN] PIPERAZINE-BASED CCR5 ANTAGONIST TABLET DOSAGE FORM<br/>[FR] FORME PHARMACEUTIQUE DE COMPRIMÉS CONTENANT UN ANTAGONISTE DU CCR5 À BASE DE PIPÉRAZINE
申请人:SCHERING CORP
公开号:WO2009134637A1
公开(公告)日:2009-11-05
Tablets containing 1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]-4-[4-[2-methoxy-1(R)-[4-(trifluoromethyl)phenyl]ethyl]-3-(S)-methyl-1-piperazinyl]-4-methyl-piperi dine or a pharmaceutically acceptable salt thereof are disclosed. Methods of making such tablets with satisfactory processability are also disclosed. In addition, methods for treating HIV as well as inflammatory diseases with an antagonist of chemokine (C-C motif) receptor 5 (CCR5) are disclosed.